CORRECTION Eevia Health Plc receives a 150 KSEK / 13 KEUR sales order for a Bilberry extract product
Due to a misjudgement, the MAR label was added to the original press release. The press release did not contain any insider information or other reason for the MAR label. This press release is a correction without the MAR label. Eevia Health Plc (”Eevia” or ”The Company”) has received a 13 KEUR sales order for Bilberry extract from its customer in South-Korea.The direct customer is a prominent South-Korean trading company headquartered in Seoul with a marketing reach across the Asian continent. The sales value to Eevia of this new order is c. 13 500 EUR. The product is a Bilberry